Literature DB >> 31740296

Asthma-COPD Overlap and Chronic Airflow Obstruction: Definitions, Management, and Unanswered Questions.

Stephen Milne1, David Mannino2, Don D Sin3.   

Abstract

Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a common clinical presentation of chronic airways disease in which patients show some features usually associated with asthma, and some usually associated with COPD. There is ongoing debate over whether ACO is a discrete clinical entity, or if it is part of a continuum of airways disease. Furthermore, there is considerable variation among current definitions of ACO, which makes diagnosis potentially challenging for clinicians. Treating ACO may be equally challenging because ACO is an understudied population, and the evidence base for its management comes largely from asthma and COPD studies, the relevance of which deserves careful consideration. In this review, we synthesize the various approaches to ACO diagnosis and evaluate the role of currently available diagnostic tests. We describe the potential benefits of existing asthma and COPD therapies in treating patients with ACO, and the value of a "treatable traits" approach to ACO management. Throughout the review, we highlight some of the pressing, unanswered questions surrounding ACO that are relevant to the clinical community. Ultimately, addressing these questions is necessary if we are to improve clinical outcomes for this complex and heterogeneous patient population.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; COPD; Diagnosis; Epidemiology; Overlap

Mesh:

Year:  2019        PMID: 31740296     DOI: 10.1016/j.jaip.2019.10.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  3 in total

1.  Effects of Air Pollutant Exposure on Exacerbation Severity in Asthma Patients with or without Reversible Airflow Obstruction.

Authors:  Wei Fang; Yu Zhang; Sinian Li; Aiming Liu; Yin Jiang; Dandan Chen; Binbin Li; Can Yao; Rongchang Chen; Fei Shi
Journal:  J Asthma Allergy       Date:  2021-09-16

2.  Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review.

Authors:  Yong Qin Lee; Asvin Selvakumar; Kay Choong See
Journal:  Cells       Date:  2021-11-22       Impact factor: 6.600

3.  The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.

Authors:  Alessandro Marcon; Francesca Locatelli; Shyamali C Dharmage; Cecilie Svanes; Joachim Heinrich; Bénédicte Leynaert; Peter Burney; Angelo Corsico; Gulser Caliskan; Lucia Calciano; Thorarinn Gislason; Christer Janson; Deborah Jarvis; Rain Jõgi; Theodore Lytras; Andrei Malinovschi; Nicole Probst-Hensch; Kjell Toren; Lidia Casas; Giuseppe Verlato; Judith Garcia-Aymerich; Simone Accordini
Journal:  Eur Respir J       Date:  2021-11-25       Impact factor: 16.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.